322 related articles for article (PubMed ID: 25827960)
1. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
4. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
5. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
Portenoy RK; Ganae-Motan ED; Allende S; Yanagihara R; Shaiova L; Weinstein S; McQuade R; Wright S; Fallon MT
J Pain; 2012 May; 13(5):438-49. PubMed ID: 22483680
[TBL] [Abstract][Full Text] [Related]
6. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
7. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis.
Markman JD; Gewandter JS; Frazer ME; Murray NM; Rast SA; McDermott MP; Chowdhry AK; Tomkinson EJ; Pilcher WH; Walter KA; Dworkin RH
Spine (Phila Pa 1976); 2015 May; 40(10):684-91. PubMed ID: 25705958
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
Portenoy RK; Messina J; Xie F; Peppin J
Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids and the cardiovascular response to stress: a pilot study of the 35% CO2 challenge in Addison's disease.
Kaye JM; Lightman SL
Clin Endocrinol (Oxf); 2006 Sep; 65(3):282-6. PubMed ID: 16918945
[TBL] [Abstract][Full Text] [Related]
13. Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial.
Hooten WM; Warner DO
Addict Behav; 2015 Mar; 42():69-72. PubMed ID: 25462656
[TBL] [Abstract][Full Text] [Related]
14. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
15. Effects of Testosterone Replacement on Pain Catastrophizing and Sleep Quality in Men with Opioid-Induced Androgen Deficiency.
Huang G; Travison TG; Edwards RR; Basaria S
Pain Med; 2017 Jun; 18(6):1070-1076. PubMed ID: 27550959
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain.
Yarlas A; Miller K; Wen W; Dain B; Lynch SY; Pergolizzi JV; Raffa RB; Ripa SR
J Pain; 2013 Jan; 14(1):14-23. PubMed ID: 23200931
[TBL] [Abstract][Full Text] [Related]
18. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone.
Small EJ; Meyer M; Marshall ME; Reyno LM; Meyers FJ; Natale RB; Lenehan PF; Chen L; Slichenmyer WJ; Eisenberger M
J Clin Oncol; 2000 Apr; 18(7):1440-50. PubMed ID: 10735891
[TBL] [Abstract][Full Text] [Related]
19. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial.
Stockler M; Vardy J; Pillai A; Warr D
J Clin Oncol; 2004 Aug; 22(16):3389-94. PubMed ID: 15310785
[TBL] [Abstract][Full Text] [Related]
20. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
